6Q0Q
Crystal structure of Human galectin-3 CRD in complex with Methyl 3-O-(1-{3-O-[1-(b-D-galactopyranosyl)-1,2,3-triazol-4-yl]-methyl-b-D-galactopyranosyl}-1,2,3-triazol-4-yl)-methyl-b-D-galactopyranoside
Summary for 6Q0Q
Entry DOI | 10.2210/pdb6q0q/pdb |
Descriptor | Galectin-3, CHLORIDE ION, (2~{R},3~{R},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-[4-[[(2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-[4-[[(2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-methoxy-3,5-bis(oxidanyl)oxan-4-yl]oxymethyl]-1,2,3-triazol-1-yl]-3,5-bis(oxidanyl)oxan-4-yl]oxymethyl]-1,2,3-triazol-1-yl]oxane-3,4,5-triol, ... (4 entities in total) |
Functional Keywords | sugar binding protein |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 16474.17 |
Authors | Kishor, C.,Blanchard, H. (deposition date: 2019-08-02, release date: 2020-04-29, Last modification date: 2024-03-13) |
Primary citation | Dussouy, C.,Kishor, C.,Lambert, A.,Lamoureux, C.,Blanchard, H.,Grandjean, C. Linear triazole-linked pseudo oligogalactosides as scaffolds for galectin inhibitor development. Chem.Biol.Drug Des., 96:1123-1133, 2020 Cited by PubMed: 32220037DOI: 10.1111/cbdd.13683 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.98601176315 Å) |
Structure validation
Download full validation report